1. Long Noncoding RNA GUSBP11 Knockdown Alleviates Nasopharyngeal Carcinoma via Regulating miR-1226-3p/TM9SF4 Axis
   Xiaofeng Zhang et al, 2024, Cancer Biotherapy and Radiopharmaceuticals CrossRef
2. Long noncoding RNA SNHG6 silencing sensitized esophageal cancer cells to 5-FU via EZH2/STAT pathway
   Ran Tan et al, 2023, Scientific Reports CrossRef
3. The mechanisms and roles of melatonin in gastrointestinal cancer
   Yong-Qiang Gong et al, 2022, Frontiers in Oncology CrossRef
4. Use of Melatonin in Cancer Treatment: Where Are We?
   Leilei Wang et al, 2022, International Journal of Molecular Sciences CrossRef
5. Melatonin: Avenues in cancer therapy and its nanotechnological advancements
   Chandra Lekha Putta et al, 2023, MedComm – Biomaterials and Applications CrossRef
6. Targeting epigenetic deregulations for the management of esophageal carcinoma: recent advances and emerging approaches
   Parul Ahuja et al, 2023, Cell Biology and Toxicology CrossRef
7. Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress
   Laura Martinez-Ruiz et al, 2023, Biomedicine & Pharmacotherapy CrossRef
8. Intra-tumor ROS amplification by melatonin interferes in the apoptosis-autophagy-inflammation-EMT collusion in the breast tumor microenvironment
   Nirmal Das et al, 2024, Heliyon CrossRef
9. Melatonin protected against kidney impairment induced by 5‐fluorouracil in mice
   Mona E. Elbanan et al, 2023, Journal of Experimental Zoology Part A: Ecological and Integrative Physiology CrossRef
10. Comparison of Efficacy and Safety of Taxanes Plus Platinum and Fluorouracil Plus Platinum in the First-Line Treatment of Esophageal Cancer: A Systematic Review and Meta-Analysis
    Yue Zhao et al, 2022, Current Oncology CrossRef
11. Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy
    Alireza Mafi et al, 2023, Cell Communication and Signaling CrossRef
12. Melatonin protects mice from 5-FU hepatotoxicity and improves 5-FU antitumor effects by an apoptotic pathway dependent on cell cycle arrest in A549 human lung cancer cells
    Mona E Elbanan et al, 2023, RPS Pharmacy and Pharmacology Reports CrossRef